John Paul Mathias

Person

Ashford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors
- Patent number 8,076,356
- Issue date Dec 13, 2011
- Pfizer Inc.
- John Paul Mathias
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydronaphthyridine derivatives
- Patent number 7,557,121
- Issue date Jul 7, 2009
- Pfizer Inc.
- Graham Lunn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
- Patent number 7,511,057
- Issue date Mar 31, 2009
- Pfizer Inc.
- John Paul Mathias
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing pharmaceutically active compounds
- Patent number 7,176,311
- Issue date Feb 13, 2007
- Pfizer Inc.
- Mark Edward Bunnage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nicotinamide derivatives useful as PDE4 inhibitors
- Patent number 7,153,870
- Issue date Dec 26, 2006
- Pfizer Inc.
- John Paul Mathias
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nicotinamide derivatives useful as PDE4 inhibitors
- Patent number 7,060,717
- Issue date Jun 13, 2006
- Pfizer Inc.
- Simon Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nicotinamide derivatives useful as PDE4 inhibitors
- Patent number 7,056,934
- Issue date Jun 6, 2006
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nicotinamide derivatives useful as PDE4 inhibitors
- Patent number 6,949,573
- Issue date Sep 27, 2005
- Pfizer Inc.
- Simon Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazolinone compounds useful in therapy
- Patent number 6,936,619
- Issue date Aug 30, 2005
- Pfizer, Inc.
- Julian Blagg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-m...
- Patent number 6,916,927
- Issue date Jul 12, 2005
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3&#x020...
- Patent number 6,723,719
- Issue date Apr 20, 2004
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutically active compounds
- Patent number 6,677,335
- Issue date Jan 13, 2004
- Pfizer Inc.
- Mark Edward Bunnage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexu...
- Patent number 6,670,366
- Issue date Dec 30, 2003
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexu...
- Patent number 6,458,951
- Issue date Oct 1, 2002
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexu...
- Patent number 6,407,114
- Issue date Jun 18, 2002
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexu...
- Patent number 6,333,330
- Issue date Dec 25, 2001
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexu...
- Patent number 6,251,904
- Issue date Jun 26, 2001
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Pharmaceutically Active Compounds
- Publication number 20100035891
- Publication date Feb 11, 2010
- Pfizer Inc.
- Mark Edward Bunnage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives
- Publication number 20090270350
- Publication date Oct 29, 2009
- Pfizer Inc.
- Balekudru Devadas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydronaphthyridine Derivatives
- Publication number 20090258861
- Publication date Oct 15, 2009
- Graham Lunn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Triazolopyridinylsulfanyl Derivatives As P38 Map Kinase Inhibitors
- Publication number 20090239899
- Publication date Sep 24, 2009
- Pfizer Inc.
- John Paul Mathias
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds
- Publication number 20090035313
- Publication date Feb 5, 2009
- Pfizer Inc.
- Christohper Gordon Barber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Triazolopyridine Compounds
- Publication number 20090012079
- Publication date Jan 8, 2009
- Russell Andrew Lewthwaite
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICALLY ACTIVE COMPOUNDS
- Publication number 20060293347
- Publication date Dec 28, 2006
- Pfizer Inc.
- Mark Edward Bunnage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nicotinamide derivatives useful as pde4 inhibitors
- Publication number 20060178408
- Publication date Aug 10, 2006
- Christopher Gordon Barber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
- Publication number 20060035922
- Publication date Feb 16, 2006
- John Paul Mathias
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nicotinamide derivatives useful as PDE4 inhibitors
- Publication number 20060014780
- Publication date Jan 19, 2006
- Pfizer Inc.
- Simon Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tetrahydronaphthyridine derivatives
- Publication number 20050256135
- Publication date Nov 17, 2005
- Graham Lunn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds
- Publication number 20050043326
- Publication date Feb 24, 2005
- Pfizer Inc.
- Christopher Gordon Barber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nicotinamide derivatives useful as PDE4 inhibitors
- Publication number 20050038033
- Publication date Feb 17, 2005
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nicotinamide derivatives useful as PDE4 inhibitors
- Publication number 20050026952
- Publication date Feb 3, 2005
- Pfizer Inc.
- John Paul Mathias
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds
- Publication number 20050020611
- Publication date Jan 27, 2005
- Christopher Gordon Barber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nicotinamide derivatives useful as PDE4 inhibitors
- Publication number 20050020626
- Publication date Jan 27, 2005
- Pfizer Inc.
- John Paul Mathias
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nicotinamide derivatives useful as PDE4 inhibitors
- Publication number 20040224975
- Publication date Nov 11, 2004
- Pfizer Inc.
- Simon Balley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-m...
- Publication number 20040180944
- Publication date Sep 16, 2004
- Pfizer Inc.
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pharmaceutically active compounds
- Publication number 20040152712
- Publication date Aug 5, 2004
- Pfizer Inc.
- Mark Edward Bunnage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds useful in therapy
- Publication number 20040029859
- Publication date Feb 12, 2004
- Pfizer Inc.
- Julian Blagg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nicotinamide derivatives useful as PDE4 inhibitors
- Publication number 20030220366
- Publication date Nov 27, 2003
- Simon Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nicotinamide derivatives and a tiotropium salt in combination for t...
- Publication number 20030220361
- Publication date Nov 27, 2003
- Simon Bailey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexu...
- Publication number 20010039271
- Publication date Nov 8, 2001
- Mark Edward Bunnage
- C07 - ORGANIC CHEMISTRY

John Paul Mathias

Person

Patents Grantslast 30 patents

Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors

Tetrahydronaphthyridine derivatives

Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors

Process for preparing pharmaceutically active compounds

Nicotinamide derivatives useful as PDE4 inhibitors

Nicotinamide derivatives useful as PDE4 inhibitors

Nicotinamide derivatives useful as PDE4 inhibitors

Nicotinamide derivatives useful as PDE4 inhibitors

Quinazolinone compounds useful in therapy

Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-m...

Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3&#x020...

Pharmaceutically active compounds

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexu...

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexu...

Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexu...

Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexu...

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexu...

Patents Applicationslast 30 patents

Pharmaceutically Active Compounds

Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives

Tetrahydronaphthyridine Derivatives

Triazolopyridinylsulfanyl Derivatives As P38 Map Kinase Inhibitors

Compounds

Triazolopyridine Compounds

PHARMACEUTICALLY ACTIVE COMPOUNDS

Nicotinamide derivatives useful as pde4 inhibitors

Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors

Nicotinamide derivatives useful as PDE4 inhibitors

Tetrahydronaphthyridine derivatives

Compounds

Nicotinamide derivatives useful as PDE4 inhibitors

Nicotinamide derivatives useful as PDE4 inhibitors

Compounds

Nicotinamide derivatives useful as PDE4 inhibitors

Nicotinamide derivatives useful as PDE4 inhibitors

Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-m...

Pharmaceutically active compounds

Compounds useful in therapy

Nicotinamide derivatives useful as PDE4 inhibitors

Nicotinamide derivatives and a tiotropium salt in combination for t...

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexu...